|
45
|
126
|
4iooA |
Crystal structure of the first bromodomain of brd4 in complex with n-methyltrimethylacetamide |
|
43
|
125
|
4hxrA |
Brd4 bromodomain 1 complex with n-[3-(2-oxo-2,3-dihydro-1,3-thiazol-4-yl)phenyl]thiophene-2-sulfonamide inhibitor |
|
41
|
125
|
4hxkA |
Brd4 bromodomain 1 complex with 6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl(1h-imidazol-1-yl)methanone inhibitor |
|
42
|
124
|
4hxsA |
Brd4 bromodomain 1 complex with n-[3-(2-oxo-2,3-dihydro-1,3-thiazol-4-yl)phenyl]-1-phenylmethanesulfonamide inhibitor |
|
42
|
116
|
4ir3A |
Crystal structure of the bromodomain of human baz2b in complex with 1-[7-amino-1-(pyrimidin-2-yl)indolizin-3-yl]ethanone (gsk2833282a) |
|
45
|
126
|
4iorA |
Crystal structure of the first bromodomain of brd4 in complex with dmso |
|
42
|
127
|
4j0sA |
Crystal structure of the first bromodomain of human brd4 in complex with a 3,5-dimethylisoxazol ligand |
|
43
|
127
|
4j3iA |
X-ray crystal structure of bromodomain complex to 1.24 a resolution |
|
41
|
116
|
4ir4A |
Crystal structure of the bromodomain of human baz2b in complex with 1-[7-(morpholin-4-yl)-1-(pyridin-2-yl)indolizin-3-yl]ethanone (gsk2834113a) |
|
43
|
125
|
4hxnA |
Brd4 bromodomain 1 complex with 4-(2-fluorophenyl)-1,3-thiazol-2(3h)-one inhibitor |
|
42
|
127
|
4j0rA |
Crystal structure of the first bromodomain of human brd4 in complex with a 3,5-dimethylisoxazol ligand |
|
40
|
116
|
4ir5A |
Crystal structure of the bromodomain of human baz2b in complex with 1-{1-[2-(hydroxymethyl)phenyl]-7-phenoxyindolizin-3-yl}ethanone (gsk2847449a) |
|
44
|
114
|
4j1pA |
X-ray crystal structure of bromodomain 2 of human brd2 in complex with rvx208 to 1.08 a resolution |
|
39
|
116
|
4ir6A |
Crystal structure of the bromodomain of human baz2b in complex with 1-{1-[2-(methylsulfonyl)phenyl]-7-phenoxyindolizin-3-yl}ethanone (gsk2838097a) |
|
44
|
124
|
4hxmA |
Brd4 bromodomain 1 complex with n-{3-(2-oxo-2,3-dihydro-1,3-thiazol-4-yl)-5-[(thiophen-2-ylsulfonyl)amino]phenyl}butanamide inhibitor |
|
44
|
124
|
4hxpA |
Brd4 bromodomain 1 complex with 4-(2-oxo-1,3-oxazolidin-3-yl)benzamide inhibitor |
|
45
|
126
|
4ioqA |
Crystal structure of the first bromodomain of brd4 in complex with pyrrolidin-2-one |
|
43
|
125
|
4hxoA |
Brd4 bromodomain 1 complex with 3-{[(3-methyl-1,2-oxazol-5-yl)methyl]sulfanyl}[1,2,4]triazolo[4,3-a]pyridine inhibitor |
|
44
|
125
|
4hxlA |
Brd4 bromodomain 1 complex with 3-cyclohexyl-n-{3-(2-oxo-2,3-dihydro-1,3-thiazol-4-yl)-5-[(thiophen-2-ylsulfonyl)amino]phenyl}propanamide inhibitor |
|
43
|
127
|
4hbxA |
Crystal structure of the first bromodomain of human brd4 in complex with a quinazolin ligand |
|
45
|
127
|
4hbvA |
Crystal structure of the first bromodomain of human brd4 in complex with a quinazolin ligand |
|
45
|
127
|
4hbwA |
Crystal structure of the first bromodomain of human brd4 in complex with a quinazoline ligand |
|
43
|
127
|
4hbyA |
Crystal structure of the first bromodomain of human brd4 in complex with a quinazolin ligand |
|
45
|
127
|
4gpjA |
Crystal structure of the first bromodomain of human brd4 in complex with a isoxazolylbenzimidazole ligand |
|
57
|
167
|
3qzvA |
Crystal structure of bptf phd-linker-bromo in complex with histone h4k12ac peptide |
|
42
|
111
|
3qzsA |
Crystal structure of bptf bromo in complex with histone h4k16ac - form i |
|
41
|
108
|
3qztA |
Crystal structure of bptf bromo in complex with histone h4k16ac - form ii |
|
35
|
106
|
4flpA |
Crystal structure of the first bromodomain of human brdt in complex with the inhibitor jq1 |
|
38
|
115
|
3q2fA |
Crystal structure of the bromodomain of human baz2b in complex with a triazolo ligand |
|
41
|
107
|
3q2eA |
Crystal structure of the second bromodomain of human bromodomain and wd repeat-containing protein 1 isoform a (wdr9) |
|
44
|
127
|
3p5oA |
Crystal structure of the first bromodomain of human brd4 in complex with ibet inhibitor |
|
38
|
119
|
3p1fA |
Crystal structure of the bromodomain of human crebbp in complex with a hydroquinazolin ligand |
|
39
|
114
|
3p1eA |
Crystal structure of the bromodomain of human crebbp in complex with dimethyl sulfoxide (dmso) |
|
40
|
115
|
3p1dA |
Crystal structure of the bromodomain of human crebbp in complex with n-methyl-2-pyrrolidone (nmp) |
|
43
|
110
|
3oniA |
Crystal structure of the second bromodomain of human brd2 in complex with the inhibitor jq1 |
|
39
|
115
|
3p1cA |
Crystal structure of the bromodomain of human crebbp in complex with acetylated lysine |
|
53
|
183
|
3o35A |
Crystal structure of trim24 phd-bromo complexed with h3(23-31)k27ac peptide |
|
47
|
182
|
3o33A |
Crystal structure of trim24 phd-bromo in the free state |
|
50
|
181
|
3o34A |
Crystal structure of trim24 phd-bromo complexed with h3(13-32)k23ac peptide |
|
51
|
182
|
3o37A |
Crystal structure of trim24 phd-bromo complexed with h3(1-10)k4 peptide |
|
55
|
184
|
3o36A |
Crystal structure of trim24 phd-bromo complexed with h4(14-19)k16ac peptide |
|
38
|
101
|
3nxbA |
Crystal structure of the bromodomain of human cecr2 |
|
44
|
127
|
3mxfA |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor jq1 |
|
46
|
126
|
3mqmA |
Crystal structure of the bromodomain of human ash1l |
|
41
|
127
|
3mukA |
Crystal structure of brd4 bromodomain 1 with propionylated histone h3-k(prop)23 |
|
40
|
127
|
3mulA |
Crystal structure of brd4 bromodomain 1 with butyrylated histone h3-k(buty)14 |
|
42
|
115
|
3mb4A |
Crystal structure of the fifth bromodomain of human poly-bromodomain containing protein 1 (pb1) with nmp |
|
49
|
135
|
3lxjA |
Crystal structure of the bromodomain of human aaa domain containing 2b (atad2b) |
|
40
|
116
|
3mb3A |
Crystal structure of the second bromodomain of pleckstrin homology domain interacting protein (phip) |
|
41
|
118
|
3ljwA |
Crystal structure of the second bromodomain of human polybromo |
